Pfenex-Agila plot cost-effective joint effort for biosimilars
This article was originally published in Scrip
Executive Summary
Pfenex and Strides Arcolab's subsidiary, Agila Biotech, have formed a joint venture to develop, manufacture and commercialize an initial pipeline of six biosimilar products globally.